Donanemab in Early Symptomatic Alzheimer Disease, The TRAILBLAZER-ALZ 2 Randomized Clinical TrialJAMA 330:512-517, 510, Sims,J.R.,et al, 2023
Cerebral MicrobleedsStroke 52:2347-2355, Graff-Radford, J.,et al, 2021